Vitrolife

Vitrolife Interest Coverage

The Interest Coverage Ratio of Vitrolife (VITR.ST) as of Nov 10, 2026 is 12.08. In the previous year, Interest Coverage Ratio was 7.53 — a change of 60.43% (higher).

Interest Coverage

12.08

YoY

60.43%

Last updated:

Interest Coverage Ratio of Vitrolife is 2025 12.08 . Interest Coverage Ratio of Vitrolife was 2024 7.53 . It decreases by 60.43% higher compared to the previous year.

The Vitrolife Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2018
540.35 SEK
Jan 1, 2019
104.76 SEK
Jan 1, 2020
38.64 SEK
Jan 1, 2021
13.38 SEK
Jan 1, 2022
8.61 SEK
Jan 1, 2023
-25.17 SEK
Jan 1, 2024
7.53 SEK
Jan 1, 2025
12.08 SEK
The Vitrolife Interest Coverage history
YEARInterest CoverageYoY
12.08+60.43%
7.53-129.91%
-25.17-392.55%
8.61-35.70%
13.38-65.36%
38.64-63.11%
104.76-80.61%
540.35+394.61%
109.25-63.13%
296.29-31.60%
433.21+987.96%
39.82—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Vitrolife Stock analysis

What does Vitrolife do? Vitrolife AB is a Swedish biotech company specializing in the development and marketing of products for in vitro fertilization (IVF) and regenerative medicine. It was founded in 1994 and has over 390 employees worldwide. The company's main business is IVF, offering a wide range of essential products for IVF treatment such as culture media, devices for semen analysis and preparation, embryo transfer techniques, and products for biopsy examinations and cryopreservation. Vitrolife has a presence in 110 countries and has expanded its market to China where there is a high demand for fertility treatments. The company also offers medical equipment for regenerative treatments. Vitrolife is a leading player in the IVF industry known for its high product quality and innovation. It collaborates with universities and research institutions globally to improve IVF technology and success rates. The company places importance on sustainability and environmental protection, using 100% animal-free ingredients in their culture media and practicing recycling and waste reduction in their production facilities. In summary, Vitrolife offers a wide range of products for IVF and regenerative medicine, with a focus on supporting IVF treatments. The company is a leader in its industry and actively participates in research. It is committed to sustainability and environmental responsibility. Vitrolife is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vitrolife stock

Interest Coverage Ratio of Vitrolife is 12.08 in 2025.

Interest Coverage Ratio of Vitrolife changed from 7.53 to 12.08, representing a 60.43% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Vitrolife since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Vitrolife with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Vitrolife

All Key Metrics — Vitrolife